GlassScriptPhysician profile
Ashley Gershner
NPI 1013540657
$709.31
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $328 · 2023: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $161.78 | 2021 | |
| Si-Bone, INC. | $122.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $117.41 | 2023 | Andexxa |
| Becton, Dickinson and Company | $99.99 | 2022 | |
| Ethicon US, LLC | $63.34 | 2023 | Ethicon, Monocryl, Echelon Flex |
| Radius Health, INC. | $38.57 | 2022 | |
| Depuy Synthes Sales INC. | $34.12 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $21.70 | 2023 | Exparel |
| Organogenesis INC. | $21.16 | 2022 | |
| Davol INC. | $15.57 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Gershner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.